Ibex Investors’s Tenet Healthcare THC Stock Holding History

Ibex Investors’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,886	Closed	-$366K	–	260
2018 Q2	$366K	Buy	+10,886	New	+$338K	0.21%	148

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

Ibex Investors's THC Position: Q3 2018 in Review

Ibex Investors sold out of Tenet Healthcare (THC) in Q3 2018, closing a stake of 10,886 shares — an estimated $366K sold.

Ibex Investors first reported a position in THC in Q2 2018 and held it in 1 quarter. The position peaked at $366K in Q2 2018. 262 funds tracked by Wall St. Rank hold THC as of Q3 2018.

Ibex Investors reported no remaining Tenet Healthcare position as of Q3 2018 after selling out during the quarter.
Ibex Investors sold 10,886 Tenet Healthcare shares in Q3 2018, an estimated $366K.
Ibex Investors first reported a position in Tenet Healthcare in Q2 2018 and held it in 1 quarter.
Ibex Investors's Tenet Healthcare position peaked at $366K in Q2 2018.
262 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2018.

Based on Ibex Investors's 13F filing for Q3 2018, filed 13 Nov 2018.